[Anti-neutrophil cytoplasmic antibody-positive interstitial lung disease: rethinking classification from a disease-spectrum perspective].

Authors

Q R Zhang, W J Guo, Q H Chen, X D Mu

Published in

Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases. Volume 49. Issue 10. Pages 1126-1128. Oct 12, 2026.

Abstract

Anti-neutrophil cytoplasmic antibodies (ANCA) positivity is not uncommon among patients with interstitial lung disease(ILD), but its clinical significance and disease classification remain poorly defined. Some patients present only with pulmonary fibrosis and show no evidence of systemic vasculitis throughout long-term follow-up, whereas others gradually develop ANCA-associated vasculitis (AAV). Current classification systems generally place such cases in the categories of AAV-associated ILD, ANCA-positive ILD, or interstitial pneumonia with autoimmune features (IPAF). However, none of these categories adequately accounts for their marked clinical heterogeneity and dynamic evolution. Recent studies suggest that ANCA-associated interstitial lung involvement may represent a disease spectrum linking pulmonary fibrosis and systemic vasculitis rather than a discrete disease entity with well-defined boundaries. Drawing on relevant research advances, this commentary examines the challenges in classifying ANCA-positive ILD and reconsiders its clinical significance from the perspectives of disease spectrum and dynamic evolution. Such an approach may provide a more comprehensive framework for understanding its biological heterogeneity and clinical behavior.

PMID:
42811571
Bibliographic data and abstract were imported from PubMed on 30 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.